Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
20 December 2019
Regulated information
Securities Note
Open in new window
20 December 2019
Financial statements and reports, Regulated information
2018 Universal Registration Document
Open in new window
24 July 2019
Financial statements and reports
2019 Half-Year Financial Report
Open in new window
13 June 2019
General meetings
Results of the votes
Open in new window
13 June 2019
General meetings
Attendance sheet
Open in new window
21 May 2019
General meetings
BALO prior notification
Open in new window
21 May 2019
General meetings
Explanatory Statement – 2019 General Meeting
Open in new window
21 May 2019
General meetings
Nominees to the Board of Directors
Open in new window
21 May 2019
General meetings
Share and voting rights statement
Open in new window
21 May 2019
General meetings
Proxy Card
Open in new window
View previous 9 articles
1
…
10
11
12
13
14
15
16
17
18
19
20
21
View next 9 articles
Go back to the page of the page